| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract Infections | 13 | 2021 | 780 | 1.670 |
Why?
|
| Vesico-Ureteral Reflux | 10 | 2021 | 424 | 1.370 |
Why?
|
| Urinary Bladder | 8 | 2021 | 1137 | 0.700 |
Why?
|
| Urography | 2 | 2015 | 326 | 0.610 |
Why?
|
| Dog Diseases | 1 | 2013 | 135 | 0.450 |
Why?
|
| Autoantibodies | 4 | 2013 | 2008 | 0.420 |
Why?
|
| Hydronephrosis | 4 | 2019 | 275 | 0.390 |
Why?
|
| Cicatrix | 3 | 2020 | 691 | 0.380 |
Why?
|
| Optic Nerve | 1 | 2013 | 553 | 0.370 |
Why?
|
| Hypospadias | 2 | 2022 | 92 | 0.350 |
Why?
|
| Bladder Exstrophy | 2 | 2020 | 92 | 0.300 |
Why?
|
| Urologic Surgical Procedures | 4 | 2020 | 295 | 0.300 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 2032 | 0.290 |
Why?
|
| Protein Array Analysis | 4 | 2013 | 412 | 0.290 |
Why?
|
| Mass Screening | 5 | 2020 | 5209 | 0.290 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2022 | 628 | 0.280 |
Why?
|
| Replantation | 2 | 2016 | 149 | 0.280 |
Why?
|
| Salmonella typhi | 3 | 2011 | 174 | 0.270 |
Why?
|
| Urologic Diseases | 2 | 2019 | 252 | 0.260 |
Why?
|
| Glaucoma | 1 | 2013 | 995 | 0.260 |
Why?
|
| Ureter | 2 | 2016 | 363 | 0.250 |
Why?
|
| Ureteroscopy | 3 | 2022 | 121 | 0.250 |
Why?
|
| Lithotripsy, Laser | 1 | 2022 | 44 | 0.220 |
Why?
|
| Orchiectomy | 2 | 2021 | 453 | 0.220 |
Why?
|
| Circumcision, Male | 2 | 2020 | 151 | 0.210 |
Why?
|
| Kidney | 5 | 2021 | 6881 | 0.210 |
Why?
|
| Cryptorchidism | 1 | 2021 | 123 | 0.200 |
Why?
|
| Dilatation, Pathologic | 2 | 2019 | 510 | 0.200 |
Why?
|
| Spermatic Cord Torsion | 1 | 2020 | 75 | 0.190 |
Why?
|
| Urologic Surgical Procedures, Male | 2 | 2017 | 90 | 0.190 |
Why?
|
| Lasers, Solid-State | 1 | 2022 | 178 | 0.190 |
Why?
|
| Child, Preschool | 23 | 2021 | 41198 | 0.190 |
Why?
|
| Infant | 20 | 2021 | 34569 | 0.190 |
Why?
|
| Typhoid Fever | 2 | 2011 | 164 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4561 | 0.180 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2124 | 0.180 |
Why?
|
| Hernia, Inguinal | 1 | 2020 | 187 | 0.180 |
Why?
|
| Urinary Tract | 2 | 2019 | 294 | 0.180 |
Why?
|
| Keratin-5 | 1 | 2017 | 45 | 0.170 |
Why?
|
| Urethral Stricture | 1 | 2017 | 58 | 0.160 |
Why?
|
| Fluoroscopy | 2 | 2018 | 899 | 0.160 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 270 | 0.160 |
Why?
|
| Retrospective Studies | 25 | 2022 | 72443 | 0.160 |
Why?
|
| Child | 28 | 2022 | 74468 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 456 | 0.150 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 1776 | 0.150 |
Why?
|
| Mood Disorders | 2 | 2013 | 1102 | 0.150 |
Why?
|
| Ultrasonography | 7 | 2021 | 5922 | 0.150 |
Why?
|
| Sperm Retrieval | 1 | 2015 | 18 | 0.150 |
Why?
|
| Sacrococcygeal Region | 1 | 2016 | 53 | 0.150 |
Why?
|
| Meningocele | 1 | 2016 | 43 | 0.140 |
Why?
|
| Klinefelter Syndrome | 1 | 2015 | 46 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2016 | 180 | 0.140 |
Why?
|
| Cystostomy | 1 | 2015 | 27 | 0.140 |
Why?
|
| Male | 49 | 2022 | 350324 | 0.140 |
Why?
|
| Bacteremia | 3 | 2011 | 969 | 0.140 |
Why?
|
| Urothelium | 1 | 2017 | 282 | 0.140 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 767 | 0.140 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 143 | 0.130 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2014 | 61 | 0.130 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2016 | 161 | 0.130 |
Why?
|
| Urinary Diversion | 1 | 2015 | 140 | 0.130 |
Why?
|
| Epidemiology | 1 | 2017 | 295 | 0.130 |
Why?
|
| Peanut Hypersensitivity | 1 | 2016 | 157 | 0.130 |
Why?
|
| Appendix | 1 | 2015 | 113 | 0.130 |
Why?
|
| Postoperative Complications | 6 | 2022 | 15079 | 0.130 |
Why?
|
| Urology | 1 | 2018 | 369 | 0.120 |
Why?
|
| Sucrose | 1 | 2014 | 186 | 0.120 |
Why?
|
| Antigens, Bacterial | 2 | 2010 | 1190 | 0.120 |
Why?
|
| Proteomics | 5 | 2021 | 3248 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2013 | 1171 | 0.120 |
Why?
|
| Siblings | 2 | 2015 | 820 | 0.120 |
Why?
|
| Spinal Dysraphism | 1 | 2015 | 152 | 0.120 |
Why?
|
| Fever of Unknown Origin | 1 | 2013 | 93 | 0.120 |
Why?
|
| Anaerobic Threshold | 1 | 2012 | 53 | 0.120 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 1669 | 0.120 |
Why?
|
| Infant, Newborn | 10 | 2020 | 24798 | 0.120 |
Why?
|
| Female | 45 | 2021 | 377204 | 0.120 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 395 | 0.120 |
Why?
|
| Urination | 3 | 2021 | 203 | 0.110 |
Why?
|
| Infertility, Male | 1 | 2015 | 407 | 0.110 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2014 | 144 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 355 | 0.110 |
Why?
|
| Humans | 65 | 2022 | 715777 | 0.110 |
Why?
|
| Cephalosporins | 1 | 2013 | 218 | 0.110 |
Why?
|
| Data Mining | 1 | 2017 | 552 | 0.110 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 328 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1179 | 0.110 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2015 | 323 | 0.110 |
Why?
|
| Cholera | 2 | 2009 | 761 | 0.110 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 311 | 0.110 |
Why?
|
| Diskectomy | 1 | 2013 | 194 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2014 | 642 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1600 | 0.110 |
Why?
|
| Spondylolisthesis | 1 | 2013 | 161 | 0.110 |
Why?
|
| Adolescent | 22 | 2021 | 85155 | 0.110 |
Why?
|
| Desensitization, Immunologic | 1 | 2016 | 485 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 250 | 0.100 |
Why?
|
| Salmonella paratyphi A | 1 | 2010 | 39 | 0.100 |
Why?
|
| Paratyphoid Fever | 1 | 2010 | 32 | 0.100 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 2021 | 79 | 0.100 |
Why?
|
| Bangladesh | 5 | 2011 | 799 | 0.100 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 252 | 0.100 |
Why?
|
| Recurrence | 5 | 2021 | 8240 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 717 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1761 | 0.090 |
Why?
|
| Antibodies, Bacterial | 3 | 2010 | 1457 | 0.090 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 69 | 0.090 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 275 | 0.090 |
Why?
|
| Helminthiasis | 1 | 2009 | 64 | 0.090 |
Why?
|
| Neutropenia | 1 | 2013 | 876 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 987 | 0.090 |
Why?
|
| Amino Acids | 1 | 2014 | 1711 | 0.090 |
Why?
|
| Medical Records | 1 | 2014 | 1423 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 1380 | 0.080 |
Why?
|
| Regeneration | 1 | 2017 | 1535 | 0.080 |
Why?
|
| Blood | 1 | 2010 | 617 | 0.080 |
Why?
|
| Dogs | 1 | 2013 | 4046 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 2011 | 3948 | 0.080 |
Why?
|
| Herpes Zoster | 1 | 2010 | 288 | 0.080 |
Why?
|
| Documentation | 1 | 2014 | 873 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2018 | 1771 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2013 | 5379 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 4040 | 0.080 |
Why?
|
| Incidence | 5 | 2019 | 20731 | 0.080 |
Why?
|
| Urine | 2 | 2020 | 381 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2013 | 507 | 0.080 |
Why?
|
| Health Resources | 1 | 2013 | 926 | 0.080 |
Why?
|
| Young Adult | 14 | 2021 | 56226 | 0.080 |
Why?
|
| Salmonella typhimurium | 1 | 2009 | 371 | 0.080 |
Why?
|
| Antigens, Neoplasm | 3 | 2011 | 1987 | 0.080 |
Why?
|
| Colon | 1 | 2015 | 1759 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 407 | 0.080 |
Why?
|
| Antipsychotic Agents | 2 | 2012 | 3062 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2014 | 2048 | 0.070 |
Why?
|
| Gene Expression Profiling | 6 | 2014 | 9504 | 0.070 |
Why?
|
| Metabolome | 1 | 2012 | 871 | 0.070 |
Why?
|
| Verbal Learning | 1 | 2008 | 477 | 0.070 |
Why?
|
| Risperidone | 1 | 2008 | 377 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2013 | 3637 | 0.070 |
Why?
|
| Quality of Life | 2 | 2017 | 11721 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 3770 | 0.070 |
Why?
|
| Vibrio cholerae | 2 | 2009 | 817 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2015 | 1923 | 0.070 |
Why?
|
| Massachusetts | 2 | 2015 | 8743 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2015 | 1840 | 0.070 |
Why?
|
| Hematologic Neoplasms | 2 | 2013 | 1688 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 617 | 0.070 |
Why?
|
| Poverty | 2 | 2013 | 2620 | 0.070 |
Why?
|
| Thiazoles | 1 | 2012 | 1515 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 452 | 0.060 |
Why?
|
| Spinal Fusion | 1 | 2013 | 1205 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2465 | 0.060 |
Why?
|
| Breast | 1 | 2012 | 1819 | 0.060 |
Why?
|
| Psychotic Disorders | 2 | 2008 | 2847 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 20062 | 0.060 |
Why?
|
| Nicotine | 1 | 2008 | 641 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 753 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1562 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 1154 | 0.060 |
Why?
|
| Holmium | 1 | 2022 | 30 | 0.060 |
Why?
|
| Observer Variation | 2 | 2019 | 2676 | 0.060 |
Why?
|
| Thulium | 1 | 2022 | 22 | 0.060 |
Why?
|
| Depressive Disorder, Major | 2 | 2012 | 4454 | 0.060 |
Why?
|
| Double-Blind Method | 5 | 2019 | 11945 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15199 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39300 | 0.060 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2015 | 2115 | 0.060 |
Why?
|
| Orchiopexy | 1 | 2021 | 14 | 0.060 |
Why?
|
| Adult | 21 | 2018 | 212266 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1192 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 2980 | 0.050 |
Why?
|
| Health Status | 1 | 2015 | 4001 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 1269 | 0.050 |
Why?
|
| Mammography | 1 | 2012 | 2490 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3681 | 0.050 |
Why?
|
| Piperazines | 1 | 2012 | 2524 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1133 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2985 | 0.050 |
Why?
|
| Decision Making | 1 | 2015 | 3846 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 7311 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2019 | 19537 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1670 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7095 | 0.050 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 2757 | 0.050 |
Why?
|
| Primary Health Care | 2 | 2013 | 4522 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2022 | 40029 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2021 | 248 | 0.050 |
Why?
|
| Penis | 1 | 2020 | 215 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3375 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 23438 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2013 | 5054 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14902 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2077 | 0.040 |
Why?
|
| Attention | 1 | 2008 | 2386 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 230 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 23464 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 415 | 0.040 |
Why?
|
| Registries | 1 | 2013 | 8045 | 0.040 |
Why?
|
| Leukocytes | 1 | 2005 | 2092 | 0.040 |
Why?
|
| Sex Factors | 3 | 2019 | 10666 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 12535 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 4905 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 572 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4893 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 9004 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2017 | 147 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 2010 | 969 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 3193 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2010 | 778 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2020 | 62004 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2020 | 8075 | 0.030 |
Why?
|
| United States | 6 | 2020 | 67905 | 0.030 |
Why?
|
| Time Factors | 4 | 2020 | 40875 | 0.030 |
Why?
|
| Skin Tests | 1 | 2016 | 646 | 0.030 |
Why?
|
| Reoperation | 2 | 2015 | 4169 | 0.030 |
Why?
|
| Middle Aged | 13 | 2015 | 214639 | 0.030 |
Why?
|
| Lung | 1 | 2013 | 9735 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 885 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 289 | 0.030 |
Why?
|
| Budesonide | 1 | 2014 | 154 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Peptides | 2 | 2020 | 4384 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 227 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2415 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 325 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2018 | 900 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12248 | 0.030 |
Why?
|
| Palpation | 1 | 2012 | 172 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 398 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9984 | 0.030 |
Why?
|
| General Practitioners | 1 | 2013 | 104 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7954 | 0.030 |
Why?
|
| Animals | 6 | 2017 | 169420 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2013 | 13213 | 0.030 |
Why?
|
| Pregnancy | 3 | 2019 | 27398 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 948 | 0.030 |
Why?
|
| Organogenesis | 1 | 2013 | 235 | 0.030 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2010 | 46 | 0.020 |
Why?
|
| Metaplasia | 1 | 2011 | 311 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 461 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2743 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18784 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1496 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1912 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 836 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1715 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 2244 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 935 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6702 | 0.020 |
Why?
|
| Vidarabine | 1 | 2010 | 348 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 219 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 34430 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2010 | 192 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 564 | 0.020 |
Why?
|
| Reference Values | 1 | 2016 | 5050 | 0.020 |
Why?
|
| Neprilysin | 1 | 2011 | 420 | 0.020 |
Why?
|
| Allergens | 1 | 2016 | 1296 | 0.020 |
Why?
|
| Infertility | 1 | 2015 | 580 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 85 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 329 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2594 | 0.020 |
Why?
|
| Risk Factors | 4 | 2015 | 70866 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2010 | 4492 | 0.020 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2008 | 88 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6105 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1829 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2928 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 2086 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 419 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2008 | 266 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2008 | 562 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1721 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2009 | 553 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9030 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2021 | 5064 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 704 | 0.020 |
Why?
|
| Inflammation | 1 | 2005 | 10081 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10435 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2137 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 1338 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 1528 | 0.020 |
Why?
|
| Mice | 4 | 2017 | 80375 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1659 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21797 | 0.020 |
Why?
|
| Vitamin A | 1 | 2008 | 630 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2599 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2198 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1785 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9377 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2008 | 964 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12456 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1602 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 6035 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2009 | 1074 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 6978 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 689 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 1053 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 421 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2973 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2015 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3524 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2222 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2550 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2371 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1104 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2729 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5265 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7757 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1140 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4824 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2942 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5397 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12480 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7140 | 0.010 |
Why?
|
| Reaction Time | 1 | 2008 | 2111 | 0.010 |
Why?
|
| Hospitals | 1 | 2014 | 3375 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1984 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 14911 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7895 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6495 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3947 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2015 | 51315 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11655 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 5031 | 0.010 |
Why?
|
| Aged | 4 | 2013 | 162448 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2463 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3638 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 2804 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6722 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2010 | 2802 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10620 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19910 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11145 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2947 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4194 | 0.010 |
Why?
|
| Exercise | 1 | 2012 | 5427 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2613 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3741 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 6873 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 12919 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 7268 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16311 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13618 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9809 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29005 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4751 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 11940 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22665 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 58323 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17409 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29291 | 0.000 |
Why?
|